Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Finasid*


Contraindicated
Indication only in men

Contraindicated
Finasid* :
Type Medicine Non Marketed
Originator Proscar
Agent Food & Drug Corporation
Distributor Food & Drug Corporation
Laboratory Saja
Responsible Party SAJA- Saudi Arabia Japanese Pharmaceutical Co
Origin KSA
Manufacturer SAJA - Saudi Arabia Japanese Pharmaceutical
Manufacturing Type G
Origin KSA
ATC G04CB01

Your comment will appear shortly after approval

Finasid* :

Revision Date : 01/05/2016


Effect Frequency
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Breast tenderness Uncommon
Depression Not known
Ejaculation decreased Common
Ejaculation disorder Uncommon
Erectile dysfunction Not known
Hepatic enzyme increased Not known
Hypersensitivity reactions Not known
Impotence Common
Infertility male Not known
Itching Not known
Libido decreased Common
Mammary hypertrophy Uncommon
Palpitations Not known
Pruritus Not known
Sexual dysfunction Not known
Skin Eruption Uncommon
Sperm analysis abnormal Not known
Testicular pain Not known
Urticaria Not known

Different Units By MoH Code

Revision Date : 01/03/2007

Finasid*  MoH 7453 :
Form Tablet, Film-Coated
Packaging Blisters
Package Size Box of 30
Strength 5mg
NSSF ✘
Quarantine ✘
Reg. Number 218579/10
Submission date 01/01/2010
Registration Year 2014
Archived Date 2017


Price Comparison

● Country: KSA
● Package Size: 30
● Public Price: 89.75 SAR ( 2,121,690.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 2,9917 SAR ( 47,280.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Bahrain
● Package Size: 30
● Public Price: 8.6 BHD ( 2,044,512.40 LBP )
● Pack size unit used: 30
● Cost/Unit: 0,2867 BHD ( 0.00 LBP )
● Reference: nhra
● Pricing Date: 09/02/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info